By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A former Sequenom patent agent and his brother have pleaded guilty to insider trading, the US Attorney for the Southern District of California said.

According to a statement from US Attorney Laura Duffy, Aaron Scalia, a former patent agent at the San Diego-based molecular diagnostics firm, and his brother Stephen Scalia, have pleaded guilty to conspiring to trade stock options in Sequenom using insider information.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.